USPTO Deadlines
Application History
21 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Oct 15, 2009 | MAB2 | O | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | Loading... |
| Oct 15, 2009 | ABN2 | O | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | Loading... |
| Mar 16, 2009 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Mar 16, 2009 | GNRT | O | NON-FINAL ACTION E-MAILED | Loading... |
| Mar 16, 2009 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Mar 3, 2009 | RCCK | S | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | Loading... |
| Sep 3, 2008 | RCSC | S | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | Loading... |
| May 9, 2008 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| May 9, 2008 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Mar 3, 2008 | RCSC | S | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | Loading... |
| Aug 31, 2007 | RCSC | S | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | Loading... |
| Feb 12, 2007 | RCSC | S | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | Loading... |
| Feb 12, 2007 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Aug 7, 2006 | RCSC | S | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | Loading... |
| Jan 24, 2006 | RCSC | S | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | Loading... |
| Jul 21, 2005 | RCSC | S | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | Loading... |
| May 27, 2005 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Jan 21, 2005 | CNSL | F | LETTER OF SUSPENSION MAILED | Loading... |
| Jan 21, 2005 | CNSL | R | SUSPENSION LETTER WRITTEN | Loading... |
| Jan 21, 2005 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jun 30, 2004 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations for use in the treatment of cardiovascular, neurological, oncological, hormonal, immunological, musculoskeletal, respiratory, alimentary and metabolic diseases and conditions; and anti-infectives
First Use Anywhere:
0
First Use in Commerce:
0
Additional Information
Pseudo Mark
IMPACTS
Classification
International Classes
005